BIO-key's (BKYI)Bottom Line Improves 51% on 13% Rise in Q2 Revenues Reflecting Strength with Government, Defense, and Financial Sector Customers Globally.
First Trust Advisors LP reduced its stake in shares of Bio-Rad Laboratories, Inc. (NYSE: BIO) by 97.3% during the undefined quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 1,522 shares of the medical research company's stock after selling 55,710 shares during
KUALA LUMPUR, MALAYSIA, Aug. 12, 2026 (GLOBE NEWSWIRE) -- Bio Green Med Solution, Inc. (NASDAQ: BGMS; "BGMS" or the "Company"), a diversified company engaged primarily in the provision of fire safety protection and distribution activities, today announced second quarter financial results and provided a business update.
Portuguese national security agency selects BIO-key (BKYI) and Visualforma to strengthen identity security with advanced IAM and biometric authentication.
HOLMDEL, N.J., Aug. 07, 2026 (GLOBE NEWSWIRE) -- BIO-key International, Inc. (NASDAQ: BKYI), a global leader in Identity and Access Management and biometric authentication technologies, will host its Q2'26 investor call and webcast on Friday, August 14th at 10 a.m.
BIO-key's proven IAM platform and Maktabi Tech's education market leadership bring global best practices and regional expertise to schools in Saudi Arabia
Amundi grew its position in Bio-Rad Laboratories, Inc. (NYSE: BIO) by 1,763.4% in the undefined quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 38,778 shares of the medical research company's stock after buying an additional 36,697 shares during the